Sentences with phrase «from systems therapy»

Triangulation is a term from systems therapy, which is a type of therapy that helps members of couples and families understand the interconnected roles and patterns that function in relationships.

Not exact matches

Reflexion's Virtual Exercise Rehabilitation Assistant (VERA) system is meant to help patients stick to the physical therapy regimens that can help them recover from those kinds of serious surgical procedures.

The winners include Laura Deming, 17, who is developing antiaging therapies; Faheem Zaman, 18, who is building mobile payment systems for developing countries; and John Burnham, 18, who is working on extracting minerals from asteroids and comets.

One of the values in Glasser's approach from a holistic growth perspective is his commitment to applying reality therapy's philosophy and principles to institutional - societal systems.

Where there is reiteration instead of reversion, there may be need of therapy, a need for new possibilities to be introduced from someone outside and therefore relatively unaffected by the reiteration (at least initially) in order to free the system to find new solutions utilizing other approaches.

The shift in their therapeutic focus is away from a primary concern with what occurs within individuals (the preoccupation of the mainstream of therapy since Freud) and toward enhancing interpersonal relationships and small social systems such as families.

It follows from this understanding of the counselor that the value system which he holds is not a matter of indifference in therapy.

Staci then went on to earn her Master of Science Degree in Family Therapy as well as a Clinical Specialist Degree in Family Systems Health Care from Nova Southeastern University in 1993.

It is a proven sleep therapy system from Sound Oasis, the leaders in sound machines.

Featuring clinically proven sounds from world renowned doctors and the world's finest authentic nature sounds, the S -650-01 Sound Oasis Sleep Sound Therapy System:

Featuring clinically proven sounds from world renowned doctors and the world's finest authentic nature sounds, the S - 665 Sound Oasis Sleep Sound Therapy System: Creates a familiar sound environment for your baby Blocks out irritating noises Helps circumvent tinnitus discomfort Creates a soothing atmosphere so you and your family can: Fall asleep easier Get higher quality sleep Enhance concentration Feel more alert and comfortable throughout the day The S - 665 sleep machine incorporates the world's only «sound card» technology which enables you to change sound themes by simply inserting a new memory card containing 12 different sounds.

Featuring clinically proven sounds from world renowned doctors and the world's finest authentic nature sounds, the S - 660 Sound Oasis Sleep Sound Therapy System: Blocks out irritating noises Helps circumvent tinnitus discomfort Creates a soothing atmosphere so you: Fall asleep easier Get higher quality sleep Enhance concentration Feel more alert and comfortable throughout the day The S - 660 sleep machine incorporates the world's only «sound card» technology which enables you to change sound themes by simply inserting a new memory card containing 12 different sounds.

Applying tools from the original osteopathic model of Dr. William Sutherland, My passion is introducing Biodynamic Craniosacral Therapy to the nervous system of my clients.

(TRM) in most of Asia, Africa, and Latin America (see sidebar on the World Health Organization?s definition of CAM and TRM), these systems include folk medicine (i.e., traditional Chinese medicine, Indian Ayurvedic medicine, and Unani medicine from the Middle East), herbal medicine, chiropractic, acupuncture, naturopathy, homeopathy, iridology, and massage therapy, to name a few.

«Steep funding cuts for the federal health agencies are counterproductive at a time when innovative research is moving us closer to identifying solutions for rare diseases, new prevention strategies to protect Americans from deadly and costly conditions, advances in gene therapy, new technologies for understanding the brain, and treatments that harness the ability of our immune system to fight cancer.»

Published in the peer - reviewed journal Systems Biology in Reproductive Medicine, the study, «Sperm RNA elements as markers of health,» from the lab of Stephen A. Krawetz, Ph.D., the Charlotte B. Failing Professor of Fetal Therapy and Diagnosis in the Wayne State Department of Obstetrics and Gynecology and Center for Molecular Medicine and Genetics, indicates that RNA found in male sperm not only shows promise as a determinant in successful live birth, it may also tell us more about the health of a child as it matures.

And early stage startup Neochromosome, which includes Boeke, intends to raise money to design synthetic chromosomes for medicine that could be used in an off - the - shelf universal cell line in cell therapies and transplants with minimal risk of rejection from the immune system.

Researchers are developing many different versions of CAR - T cell therapies, but the basic premise is the same: Doctors remove a patient's T cells (immune system cells that attack invaders) from a blood sample and genetically modify them to produce artificial proteins on their surfaces.

At the moment a lot of therapies are focused on the site of infection or injury itself but this data suggests that it's the signals that are being sent out from the gut that are impacting the whole immune system.

Instead, the therapy may benefit from the activity of the immune system operating in tandem, creating a synergistic, cancer - killing effect.

First, although there are many anecdotes from smokers who claim that e-cigarettes — properly known as electronic nicotine delivery systems — have helped them quit, so far no one has been able to show that they are more effective than nicotine replacement therapy, itself not very effective as a quitting aid.

«The ACR welcomes the introduction of biosimilars to the U.S. healthcare system and is hopeful that the decrease in cost resulting from the availability of safe and effective biosimilars in the U.S. will increase our patients» access to life - changing therapies and improve their overall health.

Thermal fluids are used to alleviate wear on components and tools and for machining operations like stamping and drilling, medical therapy and diagnosis, biopharmaceuticals, air conditioning, fuel cells, power transmission systems, solar cells, micro - and nanoelectronic mechanical systems and cooling systems for everything from engines to nuclear reactors.

The answer to increasing the effectiveness of immune therapies, or perhaps at least to choosing which patients are most likely to benefit from immune therapies, may lie in understanding the ways viruses (and cancers themselves) have evolved to evade the immune system.

Orchestrating a successful immune attack against tumors has proven difficult so far, but a new study from MIT suggests that such therapies could be improved by simultaneously activating both arms of the immune system.

Results from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person's own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after undergoing autologous stem cell transplants (ASCT).

And, in fact, these doctors and researchers are finding incredible success with this strategy; for example, PD - 1 inhibitors remove this «cloak» that cancers use to hide from the immune system, and CAR - T cell therapies use specially engineered T - cells to seek cancer - specific proteins and destroy the cancer cells to which they are attached.

Current therapies to treat pathological inflammation generally focus on quieting the overactive immune response, but in suppressing the immune system, patients are vulnerable to severe infections arising from other sources.

«This hampers integration of lipidomics into systems biology, and addressing it will improve our fundamental understanding of lipid biology, help identify new drug targets for therapy and discover lipid biomarkers from disease cohorts.»

Over the past two decades, the field has started to move from chemotherapy and radiation to targeted monoclonal antibodies and, now, to therapies that activate a patient's own immune system to fight cancer.

During her graduate training, she discovered that normal bacteria living on our skin educate the immune system and help protect us from harmful pathogens, opening the door for microbiota - based therapies in the skin.

A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.

The white paper recommends that practitioners follow relevant guidance documents and that deviation from consensus recommendations should be supported by clinical studies or pursued in the setting of a clinical trial approved by an institutional review board; that practitioners receive training in a new procedure before beginning its practice, that the training should include a practical, «hands - on» component and that all team members directly involved with the radiation therapy decisions should participate in at least five proctored cases before performing similar procedures independently; and that professional societies should accelerate the generation of new or updated guidance documents for the following disease sites and techniques: skin, central nervous system, gastrointestinal, lung or endobronchial and esophagus, and, while outside the charge of this panel, assess the need for updated guidance documents for accelerated partial breast irradiation using electronic brachytherapy.

The moves also include # 50 million ($ 78 million) for a London - based «cell therapy technology and innovation center,» and # 60 million ($ 93 million) to develop the secure system that would allow researchers access to anonymized patient data from the National Health Service (NHS).

In last January's New England Journal of Medicine study, Strollo and his colleagues reported that the therapy, with a device made by Inspire Medical Systems, reduced subjects» sleep apnea events by 68 percent, from a median of 29.3 events an hour to nine an hour, basically turning severe apnea into a mild case.

Using this system upon request from a patient, it has become possible to treat the patient ineligible for a heart transplant or destination therapy and use this technique for tunneling the internal power cable through the neck to the head, which is approved overseas, but not in Japan.

But if the immune system is involved in the new - found problems, it provides additional impetus to develop «personalised» therapies, in which neurons are grown from a patient's own cells, and so should be less likely to provoke an immune reaction.

Lastly, two sessions dedicated to disease modeling and cell therapy, respectively, will highlight ongoing attempts to study and treat diseases using stem cells from the hematopoietic and neural systems.

Geneva, Switzerland, 26 March 2014 — A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.

«Brain immune system is key to recovery from motor neuron degeneration: Results in study point to new approaches for ALS therapy.»

Many life - saving products, such as recombinant therapeutic proteins, vaccines, and gene therapy vectors, are produced from large - scale cell culture systems.

Based on findings from this study, therapies might eventually be designed to modulate the immune system in order to prevent vision loss and blindness in glaucoma patients.

In the health care industry, many life - saving products, such as recombinant therapeutic proteins, vaccines, and gene therapy vectors, are produced from large - scale cell culture systems.

ViaCyte's PEC - Encap ™ (also known as VC - 01) product candidate delivers the same cell therapy as PEC - Direct but uses a proprietary device called the Encaptra ® Cell Delivery System that is designed to protect the cells from the patient's immune sSystem that is designed to protect the cells from the patient's immune systemsystem.

While toxicity during induction is still of concern, especially in the elderly patients, we conclude from these data that de-escalation of induction therapy in elderly primary central nervous system lymphoma patients followed by maintenance treatment seems to be a promising treatment strategy.

The findings have implications for the design of cancer vaccines and what are called adoptive T cell therapies; when T cells are collected from a patient and grown in the laboratory, increasing in number before they are given back to the patient to help the immune system fight disease.

Such an immunological exemption could alleviate many concerns about using cells for therapy that don't exactly match the recipient's immune system - such as existing embryonic stem cell lines that are not directly derived from the recipient.

For cell therapy, automation can be used to increase the scale of cell culture operations (e.g., bioreactors replacing flasks) and allow the use of closed systems that can protect cell products from contamination with adventitious agents from the environment or operators themselves.

«In my view, the best benefit from stimulating the oxytocin system is going to be to combine it with a controlled behavioral therapy,» Emory's Young says.

• Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic stem cell transplant within 100 days before first dose of study drug • Known history of human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct in primary site or histology from the cancer evaluated in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study